Interestingly, a global reduction in the level of 5hmC could be revered using epigenetic approaches involving DNMT inhibitors [124] and thus, supports the notion of TET1’s involvement in reprogramming ovarian cancer epigenome [125]. This evidence concerns the gene DNMT1 and ovarian cancer.